- Supported exchanges /
- F /
- CY9D.F
Microbot Medical Inc (CY9D F) stock market data APIs
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.
Microbot Medical Inc Financial Data Overview
| 0.8615 | |
| 0.8615 | |
| - | |
| 0.8615 | |
| 0.8615 | |
| 0.7-1.79 | |
| 14 718 K | |
| 16 504 K | |
| 0 | |
| -0.35 | |
| 1.639 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Microbot Medical Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -9 410 000
- Earnings Per Share -0.72
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Microbot Medical Inc Earnings via APIs
- Latest Release 2021-06-30
- EPS/Forecast -0.35
Get Microbot Medical Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
